title: Activation of peripheral delta-opioid receptors leads to anti-hyperalgesic responses in the masseter muscle of male and female rats.
abstract: In this project, we examined peripheral δ-opioid receptor (DOR)-mediated anti-hyperalgesic responses in the context of an acute orofacial muscle pain condition in both male and female rats. We also investigated whether the ATP-sensitive K+ channel (KATP), a downstream target of OR signaling, contributes to DOR-mediated anti-hyperalgesic responses. Local pretreatment of the masseter with a DOR agonist, [D-Pen², D-Pen⁶]-enkephalin (DPDPE), dose-dependently attenuated capsaicin-induced mechanical hypersensitivity in both male and female rats. However, there were sex differences in the potency of local DPDPE in that a 10-fold higher dose of DPDPE was required in female rats to produce the level of anti-hyperalgesia achieved in male rats. The sex differences in the DPDPE effect may not be fully explained by DOR expression level since there was no significant sex difference in DOR mRNA levels in trigeminal ganglia (TG). Finally, pretreatment of the masseter with the KATP antagonist, glibenclamide, significantly blocked the effects of DPDPE in male rats suggesting that the peripheral DOR effect is mediated by the KATP. These studies revealed novel information about sex differences with regards to peripherally localized DOR-mediated anti-hyperalgesia under an orofacial muscle pain condition.
authors.affiliation: Program in Neuroscience, Department of Neural and Pain Sciences, University of Maryland Baltimore School of Dentistry, 650 W. Baltimore Street, Baltimore, MD 21201, USA.
authors.forename: J L
authors.initials: JL
authors.lastname: Saloman
authors.forename: K Y
authors.initials: KY
authors.lastname: Niu
authors.forename: J Y
authors.initials: JY
authors.lastname: Ro
mesh_terms: D000701:Analgesics, Opioid / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D020881:Enkephalin, D-Penicillamine (2,5)- / Q000494:pharmacology / Q000627:therapeutic use*; D005157:Facial Pain / Q000188:drug therapy* / Q000378:metabolism; D005260:Female; D006930:Hyperalgesia / Q000188:drug therapy* / Q000378:metabolism; D008297:Male; D008406:Masseter Muscle / Q000187:drug effects / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D017465:Receptors, Opioid, delta / Q000378:metabolism*; D012727:Sex Characteristics
chemical_list: D000701:Analgesics, Opioid; D017465:Receptors, Opioid, delta; D020881:Enkephalin, D-Penicillamine (2,5)-